The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
8-chloro-1-(1-(pyridin-2-yl)piperidin-4-yl)-5,6-dihydro-4H-benzo[f][1,2,4]triazolo[4,3-a]azepine ID: ALA4778839
PubChem CID: 162660856
Max Phase: Preclinical
Molecular Formula: C21H22ClN5
Molecular Weight: 379.89
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: Clc1ccc2c(c1)CCCc1nnc(C3CCN(c4ccccn4)CC3)n1-2
Standard InChI: InChI=1S/C21H22ClN5/c22-17-7-8-18-16(14-17)4-3-6-20-24-25-21(27(18)20)15-9-12-26(13-10-15)19-5-1-2-11-23-19/h1-2,5,7-8,11,14-15H,3-4,6,9-10,12-13H2
Standard InChI Key: RCCFFEIBQPCVBO-UHFFFAOYSA-N
Molfile:
RDKit 2D
27 31 0 0 0 0 0 0 0 0999 V2000
34.2693 -24.8747 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
33.5548 -25.2816 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.5484 -26.1008 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.2584 -26.5173 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.9730 -26.1105 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.9775 -25.2871 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.2617 -27.3370 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.6692 -28.5949 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
34.9223 -27.8179 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
33.5969 -27.8183 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
33.8565 -28.5911 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.4134 -29.2822 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.6003 -29.3694 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.0293 -28.7838 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.1263 -27.9696 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.8265 -27.5425 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.8058 -26.7244 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.0855 -26.3324 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.3847 -26.7646 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.4089 -27.5812 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.2708 -24.0615 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.9821 -23.6569 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.9864 -22.8405 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.2801 -22.4277 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.5681 -22.8372 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.5673 -23.6523 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
30.6653 -26.3769 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
1 6 1 0
2 3 1 0
3 4 1 0
4 5 1 0
5 6 1 0
7 10 1 0
11 8 2 0
8 9 1 0
9 7 2 0
4 7 1 0
10 11 1 0
11 12 1 0
10 16 1 0
12 13 1 0
13 14 1 0
15 14 1 0
15 16 2 0
16 17 1 0
17 18 2 0
18 19 1 0
19 20 2 0
20 15 1 0
21 22 2 0
22 23 1 0
23 24 2 0
24 25 1 0
25 26 2 0
26 21 1 0
1 21 1 0
19 27 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 379.89Molecular Weight (Monoisotopic): 379.1564AlogP: 4.19#Rotatable Bonds: 2Polar Surface Area: 46.84Molecular Species: NEUTRALHBA: 5HBD: ┄#RO5 Violations: ┄HBA (Lipinski): 5HBD (Lipinski): ┄#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 6.45CX LogP: 4.13CX LogD: 4.09Aromatic Rings: 3Heavy Atoms: 27QED Weighted: 0.67Np Likeness Score: -2.04
References 1. Bozó É,Baska F,Lövei K,Szántó G,Domány-Kovács K,Kurkó D,Szondiné Kordás K,Szokoli T,Bata I. (2020) New V1a receptor antagonist. Part 2. Identification and optimization of triazolobenzazepines., 30 (18.0): [PMID:32731087 ] [10.1016/j.bmcl.2020.127417 ] 2. Subbaiah MAM, Meanwell NA.. (2021) Bioisosteres of the Phenyl Ring: Recent Strategic Applications in Lead Optimization and Drug Design., 64 (19.0): [PMID:34591488 ] [10.1021/acs.jmedchem.1c01215 ]